noom glp-1 review expands its range with 'microdose' package Noom: Lose weight and keep

Explore UK clinical evidence, who may benefit, and key safety considerations.

They are usually given as injections or pills

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Weight management with GLP-1 drugs supports weight loss and improves metabolic health, reducing risks of type 2 diabetes and heart disease.

In a survey, employers told the Business Group on Health that they arent yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

Get updated info on Zepbound insurance criteria for 2025.